The National Organization for Medicines (EOF) recalls batches of a heart medication
Διαβάζεται σε 2'
The National Organization for Medicines (EOF) is recalling batches of a cardiovascular medication. The batches of the product are not being recalled due to a quality issue.
- 03 Δεκεμβρίου 2025 13:16
The National Organization for Medicines (EOF) is proceeding with the recall of a pharmaceutical product solely due to technical issues and not quality-related ones.
As EOF states, “batches of the pharmaceutical product TEZULIX PR. TAB are being recalled due to problems that arose during the transition from selling product units bearing authenticity tapes to selling units that carry a QR code.”
It is emphasized that these batches have no quality defect. The decision is issued to support the voluntary recall initiated by the company.
The company KRKA Hellas Ltd., as the product’s license holder in Greece, must immediately contact its customers in order to withdraw the product from the market.
The recalled batches are:
TEZULIX PR TAB 375 MG/TAB BTx60 tabs — EOF BARCODE 2803295901025 — Batch DE9745 — Expiry 01/2027
TEZULIX PR TAB 375 MG/TAB BTx60 tabs — EOF BARCODE 2803295901025 — Batch DD7639 — Expiry 02/2026
TEZULIX PR TAB 500 MG/TAB BTx60 tabs — EOF BARCODE 2803295902022 — Batch DD8882 — Expiry 03/2026
TEZULIX PR TAB 750 MG/TAB BTx60 tabs — EOF BARCODE 2803295903029 — Batch DE2780 — Expiry 05/2026
